PMID: 22554341May 5, 2012Paper

Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
S ChettySouth African Expert Panel

Abstract

Neuropathic pain (NeuP) is challenging to diagnose and manage, despite ongoing improved understanding of the underlying mechanisms. Many patients do not respond satisfactorily to existing treatments. There are no published guidelines for diagnosis or management of NeuP in South Africa. A multidisciplinary expert panel critically reviewed available evidence to provide consensus recommendations for diagnosis and management of NeuP in South Africa. Following accurate diagnosis of NeuP, pregabalin, gabapentin, low-dose tricyclic antidepressants (e.g. amitriptyline) and serotonin norepinephrine reuptake inhibitors (duloxetine and venlafaxine) are all recommended as first-line options for the treatment of peripheral NeuP. If the response is insufficient after 2 - 4 weeks, the recommended next step is to switch to a different class, or combine different classes of agent. Opioids should be reserved for use later in the treatment pathway, if switching drugs and combination therapy fails. For central NeuP, pregabalin or amitriptyline are recommended as first-line agents. Companion treatments (cognitive behavioural therapy and physical therapy) should be administered as part of a multidisciplinary approach. Dorsal root entry zone rhizotom...Continue Reading

References

Feb 10, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·N S LevittS Maphumolo
Dec 18, 2001·European Journal of Pain : EJP·K Meyer-RosbergA Kristofferson
Apr 24, 2004·The Journal of Pain : Official Journal of the American Pain Society·Ariel BergerGerry Oster
Apr 24, 2004·The Cochrane Database of Systematic Reviews·R M DuhmkeJ R F Hollingshead
Sep 29, 2004·Neurology·R M DubinskyUNKNOWN Quality Standards Subcommittee of the American Academy of Neurology
Apr 1, 2005·The New England Journal of Medicine·Ian GilronRobyn L Houlden
Apr 7, 2005·Palliative Medicine·P J Wiffen, UNKNOWN Cochrane Pain, Palliative and Supportive Care Group
Jul 15, 2005·PLoS Medicine·Kathleen HempenstallAndrew S C Rice
Jan 25, 2006·Journal of Palliative Medicine·Joel RaskinJ F Wernicke
Mar 10, 2006·Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique·H KheniouiR Brissot
Apr 6, 2006·Journal of Rehabilitation Research and Development·Yenisel Cruz-AlmeidaEva G Widerström-Noga
Jul 21, 2006·The Cochrane Database of Systematic Reviews·E EisenbergD B Carr
Jul 28, 2006·Current Medical Research and Opinion·Russell Portenoy
Aug 2, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Ian GilronDwight E Moulin
Aug 26, 2006·Nature Clinical Practice. Neurology·Argye E Hillis
Oct 7, 2006·Current Medical Research and Opinion·Rainer FreynhagenThomas R Tölle
Oct 14, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N AttalUNKNOWN EFNS Task Force
Dec 13, 2006·The Journal of Pain : Official Journal of the American Pain Society·Mugdha GoreBrett Stacey
Dec 22, 2006·Pain·Michael I BennettTroels Staehelin Jensen
Feb 6, 2007·European Journal of Pain : EJP·Per Hansson, Maija Haanpää
Apr 20, 2007·The Cochrane Database of Systematic Reviews·W KhaliqN Puri
Aug 28, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G CruccuR S Taylor
Jan 15, 2008·La Presse médicale·Virginie GuastellaBernard Laurent
Jul 22, 2008·The Journal of Pain : Official Journal of the American Pain Society·Brett R StaceyMichael C Rowbotham
Jul 10, 2009·The Cochrane Database of Systematic Reviews·R Andrew MooreHenry J McQuay
Aug 12, 2009·Journal of Pain & Palliative Care Pharmacotherapy·Juan Carlos AcevedoAlberto Villalobos
Aug 14, 2009·BMJ : British Medical Journal·R Freynhagen, M I Bennett
Oct 7, 2009·The American Journal of Medicine·Alec B O'Connor, Robert H Dworkin
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Michael Pt LunnPhilip J Wiffen
Mar 17, 2010·Mayo Clinic Proceedings·Robert H DworkinChristopher D Wells
Mar 17, 2010·Mayo Clinic Proceedings·Dennis C TurkSteven Stanos
Mar 20, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G CruccuR-D Treede
Apr 21, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N AttalT Nurmikko

❮ Previous
Next ❯

Citations

May 22, 2013·PloS One·Asma ShaikhPeter R Kamerman
Dec 11, 2014·BMC Musculoskeletal Disorders·Cato A BassonWitness Mudzi
Oct 17, 2019·The South African Journal of Physiotherapy·Cato A BassonAlison Rushton
Oct 27, 2016·Health & Social Care in the Community·Silvie Cooper, Leah Gilbert
Nov 13, 2013·The Cochrane Database of Systematic Reviews·Philip J WiffenEija A Kalso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Pain and Headache Reports
Douglas A DobeckiMark S Wallace
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
N AttalEFNS Task Force
© 2021 Meta ULC. All rights reserved